dr. Anna Burke is Director of the Division of Alzheimer's Disease and Memory Disorders and Karsten Solheim is Chair of Dementia at the Barrow Neurological Institute. Both authors are paid partners of Eli Lilly and Company. The article focuses on navigating the early detection and treatment of early symptomatic Alzheimer's disease. It highlights an unmet need in Alzheimer's disease.